Boerhaave syndrome is a spontaneous, full-thickness rupture of the esophagus, classically following forceful vomiting or retching. It is the most lethal gastrointestinal perforation, with mortality reaching 40–60% if treatment is delayed beyond 48 hours, but improving to ~7% when treated within 24 hours. [1-2] The classic Mackler triad — vomiting, severe chest pain, and subcutaneous cervical emphysema — is present in a minority of cases; a high index of suspicion is essential as diagnosis is delayed in >50% of cases. [1][3-4]
The following figure illustrates the multimodal diagnostic and therapeutic approach to esophageal perforation, including endoscopic, CT, and surgical findings:
1. History
- Key HPI questions: Ask about preceding forceful vomiting/retching (often alcohol-related), recent endoscopic procedures, foreign body ingestion, or chest/abdominal trauma [6-7]
- Symptom characterization: Sudden-onset severe chest or epigastric pain, often pleuritic, radiating to the back or left shoulder; may mimic MI or aortic dissection [3][7]
- Timing: Symptoms typically begin immediately after the inciting event; pain preceded by repeated vomiting is a critical history to elicit [7]
- Associated symptoms: Dysphagia, odynophagia, dyspnea, hematemesis (rare), hypersalivation [8]
- Important negatives: Absence of classic triad does NOT rule out perforation — symptoms are unreliably present [3][8]
2. Alarm Features
- Mackler triad: Vomiting + chest pain + subcutaneous emphysema (pathognomonic but uncommon) [1]
- Hemodynamic instability, tachycardia, fever, signs of sepsis or septic shock [2][8]
- Rapidly progressive subcutaneous emphysema (neck, chest wall)
- New-onset pleural effusion (especially left-sided) or pneumothorax
- Respiratory distress or failure
- Signs of mediastinitis: high fever, rigors, tachycardia out of proportion to fever
- Nearly 25% of patients are septic at time of hospital admission [2]
3. Medications
- Broad-spectrum IV antibiotics covering aerobes and anaerobes: piperacillin-tazobactam (preferred), ampicillin-sulbactam, or a carbapenem [8]
- Antifungals (fluconazole): Indicated in patients on chronic PPIs, chronic steroids/immunosuppressants, known esophageal candidiasis, or HIV [8]
- IV proton pump inhibitors to reduce acid exposure to the perforation site [3]
- Vasopressors if hemodynamically unstable despite fluid resuscitation [3]
- Avoid oral medications — patient must be NPO [8]
4. Diet
- Strict NPO immediately upon suspicion [8]
- Early nutritional support via enteral feeding tube (placed under direct visualization) or total parenteral nutrition (TPN) is essential for esophageal healing [4]
- Oral intake resumed only after contrast study confirms no leak, typically after 5–7 days of conservative management [8]
5. Review of Systems
- Pulmonary: Dyspnea, pleuritic chest pain, cough
- GI: Dysphagia, odynophagia, hematemesis, epigastric pain, nausea/vomiting history
- Cardiovascular: Chest pain character (distinguish from ACS/dissection)
- Constitutional: Fever, chills, rigors (suggest mediastinitis/sepsis)
- Neck: Swelling, crepitus, voice changes (cervical perforation) [2][7]
6. Collateral History and Family History
- Alcohol use history: Heavy alcohol consumption is a classic precipitant of forceful vomiting leading to Boerhaave [6]
- Recent procedures: Any recent EGD, esophageal dilation, stent placement, TEE, or difficult intubation (iatrogenic causes account for ~50% of all esophageal perforations) [9-10]
- Eating disorders: Bulimia with repeated self-induced vomiting
- Prior esophageal disease: History of strictures, achalasia, eosinophilic esophagitis, Barrett's, or esophageal malignancy
- Family history is generally not contributory
7. Risk Factors
- Forceful/prolonged vomiting or retching (alcohol binge, hyperemesis, post-anesthesia) [1][6]
- Iatrogenic instrumentation: EGD, dilation, stenting, TEE — most common overall cause of esophageal perforation [9][11]
- Foreign body ingestion
- Pre-existing esophageal pathology: Strictures, achalasia, eosinophilic esophagitis, malignancy [9]
- Male sex (~70–78% of cases), age 50–70 years [1][12-13]
- Straining (heavy lifting, seizures, childbirth, defecation)
8. Differential Diagnosis
- Acute coronary syndrome / myocardial infarction — chest pain, diaphoresis; ECG and troponin differentiate
- Aortic dissection — tearing chest/back pain; CT angiography differentiates
- Tension pneumothorax — dyspnea, absent breath sounds, tracheal deviation
- Pulmonary embolism — pleuritic pain, dyspnea, hypoxia
- Perforated peptic ulcer — epigastric pain, peritonitis, free air under diaphragm
- Acute pancreatitis — epigastric pain radiating to back, elevated lipase
- Mallory-Weiss tear — partial-thickness mucosal tear (hematemesis without perforation); distinguished from Boerhaave by absence of mediastinal air/fluid [1]
- Mediastinitis from other causes (descending necrotizing mediastinitis from odontogenic infection)
- Esophageal intramural hematoma — CT can differentiate [4]
9. Past Medical History
- Prior esophageal surgery or foregut operations
- Known esophageal stricture, achalasia, or malignancy [9]
- History of prior perforation or esophageal instrumentation
- Chronic GERD or Barrett's esophagus
- Immunosuppression (affects antibiotic/antifungal selection) [8]
- Connective tissue disorders (Ehlers-Danlos, Marfan — increased tissue fragility)
10. Physical Exam
- Vital signs: Tachycardia, tachypnea, fever, hypotension (late/ominous) [2]
- Neck: Subcutaneous emphysema/crepitus — palpable in 60% of cervical perforations, only ~33% of thoracic perforations [2]
- Chest: Decreased breath sounds (effusion/pneumothorax), Hamman's sign (mediastinal crunch — crunching sound synchronous with heartbeat on auscultation)
- Abdomen: Epigastric tenderness, guarding (if distal/GEJ perforation with peritoneal contamination)
- General: Diaphoresis, toxic appearance, signs of sepsis
- Pearl: Physical exam is unreliable for early diagnosis — absence of findings does NOT exclude perforation [4][8]
11. Lab Studies
- CBC: Leukocytosis (nonspecific, related to inflammatory response) [4]
- BMP/CMP: Creatinine, electrolytes (assess renal function, dehydration)
- Lactate: Elevated in sepsis/shock
- Blood cultures: If febrile or septic
- ABG/VBG: Assess for acidosis
- CRP/Procalcitonin: Elevated but nonspecific [4]
- Type and screen: Anticipate potential surgical intervention
- Amylase: Pleural fluid amylase (salivary isoenzyme) may be elevated — suggestive of esophageal perforation if found in pleural effusion
- Pearl: No lab test is diagnostic; labs are nonspecific and reflect the inflammatory/septic response rather than the perforation itself [4]
12. Imaging
- First-line: Contrast-enhanced CT with oral contrast (CT esophagography) — sensitivity 92–100%, NPV 100%; imaging examination of choice per WSES guidelines [4][14]
- Key findings: Extraluminal air/oral contrast, pneumomediastinum, mediastinal fluid, pleural effusion, esophageal wall disruption [4][15]
- CT without pleural/mediastinal fluid has 100% NPV for perforation [16]
- Chest X-ray: Indirect findings in ~90% — pneumomediastinum, subcutaneous emphysema, pleural effusion (often left-sided), pneumothorax, widened mediastinum; may be normal early [2][4]
- Fluoroscopic contrast esophagography: Water-soluble contrast (Gastrografin) first; if negative, follow with barium. Sensitivity lower than CT (~70%); largely supplanted by CT esophagography [2][14]
- When imaging is unnecessary: CT with oral contrast that shows no pneumomediastinum, no mediastinal/pleural fluid effectively rules out perforation [14][16]
13. Special Tests
- Pittsburgh Esophageal Perforation Severity Score (PSS): Validated scoring system based on 10 clinical and radiological factors; scores ≤2 may be eligible for nonoperative management; higher scores correlate with increased morbidity and mortality [4][17]
- Esophagoscopy: Sensitivity 96–100%, specificity 92–100% for direct visualization of perforation; also allows therapeutic intervention [8]
- Pleural fluid analysis: Elevated salivary amylase, low pH, food particles — highly suggestive
- AAST Esophagus Injury Scale: Grades I–V for injury severity classification [8]
14. ECG
- Obtain ECG to rule out acute coronary syndrome, as chest pain presentation overlaps significantly
- Boerhaave itself does not produce specific ECG changes
- May show sinus tachycardia or nonspecific ST changes from mediastinal inflammation
- Dangerous patterns to recognize: ST elevation (STEMI mimic from mediastinal irritation vs. true ACS), new arrhythmias from mediastinal sepsis
15. Assessment
- Clinical summary: Boerhaave syndrome is a surgical emergency. The perforation most commonly occurs on the left posterolateral distal esophagus (above the GEJ). Mediastinal contamination with gastric contents, saliva, and bacteria leads to chemical and bacterial mediastinitis, progressing rapidly to sepsis and multiorgan failure. [7][9]
- Severity stratification: Use the Pittsburgh PSS — low (≤2), intermediate (3–5), high (>5). High PSS patients are 3.37× more likely to require operative management. [17]
- Typical presentation: Male, 50–70 years, post-vomiting chest pain with subcutaneous emphysema
- Atypical presentations: Isolated back pain, epigastric pain mimicking pancreatitis, isolated dyspnea, or delayed presentation with sepsis and no clear history of vomiting [3][6]
- Complications: Mediastinitis, empyema, sepsis, multiorgan failure, esophageal stricture, fistula formation, death [2]
16. Treatment Plan
Initial stabilization (ED)
- Secure airway if needed (avoid blind NG tube placement; consider endoscopic guidance) [3][8]
- Large-bore IV access, aggressive fluid resuscitation with crystalloid [8]
- NPO immediately [8]
- Broad-spectrum IV antibiotics: Piperacillin-tazobactam 4.5 g IV q6h (or meropenem) [8]
- IV PPI (e.g., pantoprazole 40 mg IV) [3]
- Fluconazole if immunosuppressed, chronic PPI use, or known candidiasis [8]
- Nasogastric tube for gastric decompression (placed under endoscopic guidance if possible) [10]
- Vasopressors if refractory hypotension [3]
Definitive management (multidisciplinary — thoracic surgery, GI, IR, critical care):
- Surgical primary repair + drainage: Remains the cornerstone; mortality ~13% [4][13]
- Endoscopic therapy (stenting, clipping, endoscopic vacuum therapy): Comparable survival to surgery but higher re-intervention rates (OR 4.55); best for early, contained perforations [13][18-19]
- Nonoperative management: Reserved for stable patients with contained perforation, minimal contamination, and no sepsis — NPO, antibiotics, drainage of collections [4][8]
- Esophagectomy: Reserved for extensive necrosis, malignancy, or end-stage esophageal disease [10]
- Nutritional support: Early enteral feeding or TPN [4]
17. Disposition
- All confirmed or strongly suspected esophageal perforations require ICU admission [3][8]
- Admission criteria: Any confirmed perforation, hemodynamic instability, sepsis, mediastinal contamination, need for surgical/endoscopic intervention
- Transfer criteria: If thoracic surgery and interventional endoscopy are not available, emergent transfer to a tertiary center with esophageal surgery capability [20]
- Observation: Not appropriate — this is not an observation-level diagnosis
- Specialist consultation triggers: Thoracic surgery (always), gastroenterology, interventional radiology, critical care [3]
18. Follow Up / Return Precautions
- In-hospital: Median hospital stay is 27–32 days; median ICU stay ~8 days [12][20]
- Contrast esophagography at 5–7 days to confirm healing before resuming oral intake [8]
- 90-day mortality: ~12–19% overall; significantly higher with delayed diagnosis (>24 hours) [12][20-21]
- Post-discharge follow-up: Thoracic surgery and GI follow-up within 1–2 weeks; repeat imaging if symptoms recur
- Return precautions: Fever, recurrent chest/back pain, dysphagia, dyspnea, neck swelling, or signs of wound infection should prompt immediate return
- Long-term complications to monitor: Esophageal stricture, fistula, recurrent perforation, chronic mediastinal collections
- Expected recovery: Prolonged; full recovery may take weeks to months depending on severity and treatment approach
References
1. Boerhaave Syndrome. Case Report and Literature Review. — Salvador-Ibarra IJ, Pizaña-Davila A. Cirugia Y Cirujanos. 2021.
2. Management of Iatrogenic Cervical Esophageal Perforations: A Narrative Review. — Chen S, Shapira-Galitz Y, Garber D, Amin MR. JAMA Otolaryngology-- Head & Neck Surgery. 2020.
3. High Risk and Low Prevalence Diseases: Esophageal Perforation. — DeVivo A, Sheng AY, Koyfman A, Long B. The American Journal of Emergency Medicine. 2022.
4. Esophageal Emergencies: WSES Guidelines. — Chirica M, Kelly MD, Siboni S, et al. World Journal of Emergency Surgery : WJES. 2019.
5. Rupture and Perforation of the Esophagus. — Phillip S. Ge, Gottumukkala S. Raju The Esophagus. 2021.
6. Challenges in the Diagnosis of Boerhaave Syndrome: A Case Report. — Tzeng CH, Chen WK, Lu HC, et al. Medicine. 2020.
7. Oesophageal Injuries: Position Paper, WSES, 2013. — Ivatury RR, Moore FA, Biffl W, et al. World Journal of Emergency Surgery : WJES. 2014.
8. Gastrointestinal Surgical Emergencies Textbook. — Ashley E. Aaron, Andrea Amabile, Ciro Andolfi, et al American College of Surgeons (2021). 2021.
9. The Etiology, Diagnosis, and Management of Esophageal Perforation. — Khaitan PG, Famiglietti A, Watson TJ. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract. 2022.
10. The Insidious Presentation and Challenging Management of Esophageal Perforation Following Diagnostic and Therapeutic Interventions. — Lampridis S, Mitsos S, Hayward M, Lawrence D, Panagiotopoulos N. Journal of Thoracic Disease. 2020.
11. Endoscopic Management of Esophageal Perforations: A Multi-Center Study. — Aburumman R, Abdul Razzak F, Kerbage A, et al. Surgical Endoscopy. 2025.
12. Treatment Strategies for Boerhaave Syndrome: Multinational Retrospective Cohort Study. — Hauge T, Abu Hejleh A, Aiolfi A, et al. The British Journal of Surgery. 2025.
13. Surgical Versus Endoscopic Management of Boerhaave's Syndrome: A Systematic Review and Meta-Analysis. — Reback T, Butterworth J, Strong S, et al. Annals of the Royal College of Surgeons of England. 2026.
14. Diagnostic Utility of CT and Fluoroscopic Esophagography for Suspected Esophageal Perforation in the Emergency Department. — Wei CJ, Levenson RB, Lee KS. AJR. American Journal of Roentgenology. 2020.
15. Predictive Criteria for Oesophageal Perforation in Patients With Pneumomediastinum: Can Invasive Diagnostic Modalities Be Avoided?. — Hsieh JM, Cheng DT, Scott J, Thomson I, Frankel A. Emergency Medicine Journal : EMJ. 2026.
16. Diagnostic Utility of Computed Tomography in Patients With Spontaneous Pneumomediastinum Evaluated for Suspected Esophageal Perforation. — Keogan AG, Rybachok A, Patel S, et al. World Journal of Surgery. 2025.
17. Spotlight on Esophageal Perforation: A Multinational Study Using the Pittsburgh Esophageal Perforation Severity Scoring System. — Schweigert M, Sousa HS, Solymosi N, et al. The Journal of Thoracic and Cardiovascular Surgery. 2016.
18. Endoscopic Vacuum Therapy for the Treatment of Boerhaave Syndrome: A Multicenter Analysis. — Wannhoff A, Kouladouros K, Koschny R, et al. Gastrointestinal Endoscopy. 2025.
19. Surgical Versus Endoscopic Management of Esophageal Perforation. — Wang KJ, Alexander EV, Worrell SG. Current Opinion in Gastroenterology. 2025.
20. Treatment of Boerhaave Syndrome: Experience From a Tertiary Center. — Kooij CD, Boptsi E, Weusten BLAM, et al. Surgical Endoscopy. 2025.
21. Multicenter, Prospective Cohort Study of Oesophageal Injuries and Related Clinical Outcomes (MUSOIC Study). — Owen RP, Chidambaram S, Griffiths EA, et al. Annals of Surgery. 2023.